CHAOJU EYE CARE (02219) spent approximately HKD 672,800 to repurchase 268,000 shares on September 7.
Zhao Ju Eye Care (02219) announced that on September 7, 2026, the company spent approximately HKD 672,800 to repurchase 268,000 shares at a price of HKD 2.46 to HKD 2.55 per share.
CHAOJU EYE CARE (02219) announced that on September 7, 2026, the company spent approximately HKD 672,800 to repurchase 268,000 shares, with a repurchase price ranging from HKD 2.46 to HKD 2.55 per share.
Related Articles
TIMES CHINA (01233) reported a cumulative contract sales amount of approximately 2.237 billion yuan in the first eight months, a year-on-year decrease of 38.41%.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-1179 Injection has obtained the Clinical Trial Approval Notification.
Nanchang Jiahui, a shareholder of Jiangxi Guoke Defence Group (688543.SH), intends to reduce its holdings by no more than 3%.
TIMES CHINA (01233) reported a cumulative contract sales amount of approximately 2.237 billion yuan in the first eight months, a year-on-year decrease of 38.41%.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-1179 Injection has obtained the Clinical Trial Approval Notification.
Nanchang Jiahui, a shareholder of Jiangxi Guoke Defence Group (688543.SH), intends to reduce its holdings by no more than 3%.
RECOMMEND
